Financial Times: FDA Commissioner Stephen Hahn says his agency is prepared to authorize a coronavirus vaccine before Phase Three clinical trials are complete, as long as officials believe the benefits outweigh the risks. https://t.co/78toTllz5g

— Geoff Bennett (@GeoffRBennett) August 30, 2020